American Society of Clinical Oncology

Recent papers from American Society of Clinical Oncology

1. PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0Journal of Clinical Oncology · 2026
2. Treatment of Advanced Biliary Tract Cancer: ASCO Living Guideline, Version 2026.1.0Journal of Clinical Oncology · 2026
3. Promoting High-Quality, Accessible Cancer Care for People With DisabilitiesJCO Oncology Practice · 2026
4. Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3Journal of Clinical Oncology · 2026
5. Geographic access to triple negative breast cancer clinical trials: are trials located near patients?Breast Cancer Research and Treatment · 2026
6. Sunitinib in Patients With Various Solid Tumors With FGFR1 / 2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyJCO Precision Oncology · 2026
7. Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0Journal of Clinical Oncology · 2026
8. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3Journal of Clinical Oncology · 2026
9. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2Journal of Clinical Oncology · 2026
10. Optimizing Oncology Care Through Collaborative TeamsJCO Oncology Practice · 2026
11. Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4Journal of Clinical Oncology · 2026
12. Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline UpdateJournal of Clinical Oncology · 2026
13. Apple Vision Pro as a wearable display for endoscopic dacryocystorhinostomy: Surgical experience, efficiency, and costAJO International · 2026
14. Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0Journal of Clinical Oncology · 2026
15. Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007)JNCI Journal of the National Cancer Institute · 2026
16. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2Journal of Clinical Oncology · 2026
17. Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyJCO Precision Oncology · 2026
18. Integrating Artificial Intelligence and Automation Into Living Guideline Development: A Scoping Review of Existing Frameworks, Methods, and ApplicationsClinical and Public Health Guidelines · 2026
19. Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO GuidelineJCO Oncology Practice · 2026
20. HER2 status assessment in carcinomas of various localizations. A multicenter morphological study in the Russian FederationRussian Journal of Archive of Pathology · 2026